Clinical trial
Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
NCT02743364 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 19, 2016
- Completion date
- May 11, 2022
- Enrollment
- 8 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
acute pancreatitis